IDACIO

fresenius kabi canada ltd🇨🇦 Health Canada

Approval Id: 7d7834113d6e8a0d
Drug Approval Canada Name: IDACIO
Product Name: IDACIO
Status: Marketed
Status Date: 2021-08-30
Original Market Date: 2021-08-30
Din: 02502682
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 90:24.16.92
Atc Original: L04AB04 ADALIMUMAB
Atc Name: l 04 ab 04
Aig Number: 0150364003
Company Name: fresenius kabi canada ltd
Company Address: 165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8

ADALIMUMAB

40 MG / 0.8 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

7d7834113d6e8a0d

Type

Standard